ELOXX PHARMACEUTICALS, INC. (ELOX) Net income 2016–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.0MFY2025 · since FY2016: -$9.8M → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | -90.7% |
| FY2024 | -$3.1M | +81.6% |
| FY2023 | -$17.1M | +52.7% |
| FY2022 | -$36.1M | +46.0% |
| FY2021 | -$66.7M | -93.0% |
| FY2020 | -$34.6M | +32.0% |
| FY2019 | -$50.9M | -7.8% |
| FY2018 | -$47.2M | -122.4% |
| FY2017 | -$21.2M | -115.4% |
| FY2016 | -$9.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice